$DXCM
DEXCOM INC Stock $dxcm

$dxcm Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000109355716000624 Filed on August 02, 2016

Income Statement

Concept	2016 Q3	2016 Q2	2015 Q2
Revenue	$148.6M	$137.3M	$93.20M
YoY Change	41.25%	47.32%	58.5%
Cost Of Revenue	$47.50M	$51.80M	$27.20M
YoY Change	55.74%	90.44%	43.92%
Gross Profit	$101.1M	$85.50M	$66.00M
YoY Change	35.34%	29.55%	65.41%
Gross Profit Margin	68.03%	62.27%	70.82%
Selling, General & Admin	$75.70M	$69.30M	$45.20M
YoY Change	44.74%	53.32%	46.28%
% of Gross Profit	74.88%	81.05%	68.48%
Research & Development	$43.90M	$36.30M	$24.40M
YoY Change	-32.25%	48.77%	64.86%
% of Gross Profit	43.42%	42.46%	36.97%
Depreciation & Amortization	$4.100M	$3.900M	$2.600M
YoY Change	51.85%	50.0%	36.84%
% of Gross Profit	4.06%	4.56%	3.94%
Operating Expenses	$119.6M	$105.6M	$69.60M
YoY Change	2.13%	51.72%	52.3%
Operating Profit	-$18.50M	-$20.10M	-$3.600M
YoY Change	-56.37%	458.33%	-37.93%
Interest Expense	$200.0K	$100.0K	$100.0K
YoY Change	100.0%	0.0%	-50.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00
YoY Change
Pretax Income	-$18.60M	-$20.10M	-$3.700M
YoY Change	-56.24%	443.24%	-38.33%
Income Tax	$200.0K	$100.0K	$0.00
% Of Pretax Income
Net Earnings	-$18.80M	-$20.20M	-$3.700M
YoY Change	-55.76%	445.95%	-38.33%
Net Earnings / Revenue	-12.65%	-14.71%	-3.97%
Basic Earnings Per Share
Diluted Earnings Per Share	-$223.5K	-$241.6K	-$46.48K
COMMON SHARES
Basic Shares Outstanding	83.88M shares	83.60M shares	79.60M shares
Diluted Shares Outstanding		83.60M shares	79.60M shares

Balance Sheet

Concept	2016 Q3	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$127.3M	$115.6M	$97.50M
YoY Change	12.36%	18.56%	59.05%
Cash & Equivalents	$97.70M	$87.50M	$67.70M
Short-Term Investments	$29.60M	$28.10M	$29.80M
Other Short-Term Assets	$9.800M	$8.700M	$5.000M
YoY Change	145.0%	74.0%	25.0%
Inventory	$44.70M	$42.90M	$22.40M
Prepaid Expenses
Receivables	$76.80M	$73.80M	$45.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$258.6M	$241.0M	$170.4M
YoY Change	26.95%	41.43%	61.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$88.40M	$77.00M	$40.60M
YoY Change	89.7%	89.66%	56.15%
Goodwill	$11.80M	$11.80M	$3.700M
YoY Change	218.92%	218.92%	15.63%
Intangibles	$1.600M	$1.800M	$2.500M
YoY Change	-33.33%	-28.0%	-24.24%
Long-Term Investments
YoY Change
Other Assets	$1.500M	$1.200M	$500.0K
YoY Change	400.0%	140.0%	-28.57%
Total Long-Term Assets	$103.3M	$91.80M	$48.00M
YoY Change	94.91%	91.25%	40.35%
TOTAL ASSETS
Total Short-Term Assets	$258.6M	$241.0M	$170.4M
Total Long-Term Assets	$103.3M	$91.80M	$48.00M
Total Assets	$361.9M	$332.8M	$218.4M
YoY Change	40.98%	52.38%	56.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.30M	$22.40M	$11.70M
YoY Change	57.49%	91.45%	67.14%
Accrued Expenses	$59.30M	$50.80M	$29.30M
YoY Change	56.05%	73.38%	12.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$2.400M
YoY Change	-100.0%	-100.0%	4.35%
Total Short-Term Liabilities	$86.10M	$73.90M	$44.20M
YoY Change	46.43%	67.19%	24.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.100M
YoY Change	-100.0%	-100.0%	-68.57%
Other Long-Term Liabilities	$14.00M	$12.50M	$2.400M
YoY Change	233.33%	420.83%	140.0%
Total Long-Term Liabilities	$14.00M	$12.50M	$2.400M
YoY Change	233.33%	420.83%	140.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$86.10M	$73.90M	$44.20M
Total Long-Term Liabilities	$14.00M	$12.50M	$2.400M
Total Liabilities	$100.1M	$86.40M	$47.70M
YoY Change	57.89%	81.13%	18.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$613.6M	-$594.8M	-$514.4M
YoY Change	10.18%	15.63%	4.15%
Common Stock	$876.0M	$841.8M	$685.3M
YoY Change	16.74%	22.84%	15.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$261.8M	$246.4M	$170.7M
YoY Change
Total Liabilities & Shareholders Equity	$361.9M	$332.8M	$218.4M
YoY Change	40.98%	52.38%	56.34%

Cashflow Statement

Concept	2016 Q3	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$18.80M	-$20.20M	-$3.700M
YoY Change	-55.76%	445.95%	-38.33%
Depreciation, Depletion And Amortization	$4.100M	$3.900M	$2.600M
YoY Change	51.85%	50.0%	36.84%
Cash From Operating Activities	$23.00M	$20.10M	$16.40M
YoY Change	28.49%	22.56%	164.52%
INVESTING ACTIVITIES
Capital Expenditures	-$16.10M	-$10.50M	-$6.300M
YoY Change	117.57%	66.67%	57.5%
Acquisitions
YoY Change
Other Investing Activities	-$1.700M	$900.0K	-$900.0K
YoY Change	-200.0%	-200.0%
Cash From Investing Activities	-$17.80M	-$9.600M	-$7.200M
YoY Change	212.28%	33.33%	80.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.100M	-700.0K	4.300M
YoY Change	-5.56%	-116.28%	168.75%
NET CHANGE
Cash From Operating Activities	23.00M	20.10M	16.40M
Cash From Investing Activities	-17.80M	-9.600M	-7.200M
Cash From Financing Activities	5.100M	-700.0K	4.300M
Net Change In Cash	10.30M	9.800M	13.50M
YoY Change	-41.48%	-27.41%	255.26%
FREE CASH FLOW
Cash From Operating Activities	$23.00M	$20.10M	$16.40M
Capital Expenditures	-$16.10M	-$10.50M	-$6.300M
Free Cash Flow	$39.10M	$30.60M	$22.70M
YoY Change	54.55%	34.8%	122.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7300000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-200000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dxcm	Acquisitionrelatedholdbackliability Acquisitionrelatedholdbackliability	1800000	USD
	dxcm	Capitalized Costs And Financing Liability CapitalizedCostsAndFinancingLiability	0	USD
	dxcm	Capitalized Costs And Financing Liability CapitalizedCostsAndFinancingLiability	6000000	USD
	dei	Entity Registrant Name EntityRegistrantName	DEXCOM INC
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001093557
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	83883617	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Trading Symbol TradingSymbol	DXCM
CY2015Q4	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	2100000	USD
CY2016Q2	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	3300000	USD
	dxcm	Acquisitionrelatedholdbackliability Acquisitionrelatedholdbackliability	0	USD
CY2015Q4	dxcm	Clinical Trials ClinicalTrials	700000	USD
CY2016Q2	dxcm	Clinical Trials ClinicalTrials	500000	USD
CY2015Q2	dxcm	Development Grant And Other Revenue DevelopmentGrantAndOtherRevenue	300000	USD
	dxcm	Development Grant And Other Revenue DevelopmentGrantAndOtherRevenue	300000	USD
CY2016Q2	dxcm	Development Grant And Other Revenue DevelopmentGrantAndOtherRevenue	0	USD
	dxcm	Development Grant And Other Revenue DevelopmentGrantAndOtherRevenue	0	USD
CY2015Q4	dxcm	Financing Lease Obligation Mesa Building FinancingLeaseObligationMesaBuilding	0	USD
CY2016Q2	dxcm	Financing Lease Obligation Mesa Building FinancingLeaseObligationMesaBuilding	6000000	USD
CY2015Q4	dxcm	Pharmacy Rebates PharmacyRebates	4000000	USD
CY2016Q2	dxcm	Pharmacy Rebates PharmacyRebates	5200000	USD
	dxcm	Potential Rental Rate Adjustment Maximum PotentialRentalRateAdjustmentMaximum	0.04
	dxcm	Potential Rental Rate Adjustment Minimum PotentialRentalRateAdjustmentMinimum	0.025
	dxcm	Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm	P1Y
	dxcm	Sales Return Coverage Period SalesReturnCoveragePeriod	P30D
CY2012Q4	dxcm	Term Loan Advances Aggregate Amount TermLoanAdvancesAggregateAmount	7000000	USD
CY2012Q4	dxcm	Term Loan Debt TermLoanDebt	20000000	USD
CY2016Q2	dxcm	Working Capital WorkingCapital	167100000	USD
CY2015Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	38900000	USD
CY2016Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	49900000	USD
CY2015Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	19000000	USD
CY2016Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	22400000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	74100000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	73800000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-200000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-100000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-300000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-700000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	776800000	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	841800000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	100000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6500000	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4900000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4900000	shares
CY2015Q4	us-gaap	Assets Assets	292000000	USD
CY2016Q2	us-gaap	Assets Assets	332800000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	231300000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	241000000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	29100000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	28100000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	29100000	USD
CY2016Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	28100000	USD
CY2016Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	27000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29100000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	28100000	USD
CY2016Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	1100000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71800000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67700000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86100000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87500000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1400000	USD
CY2016Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	115600000	USD
CY2015Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	32100000	USD
CY2016Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	33300000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84100000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81700000	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	83800000	shares
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2016Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3700000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16800000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39800000	USD
CY2016Q2	us-gaap	Contractual Obligation ContractualObligation	30000000	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	27200000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	53500000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	51800000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	92900000	USD
CY2012Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	13000000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3800000	USD
CY2016Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4300000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	800000	USD
CY2016Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	700000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	24900000	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23300000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	202800000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-200000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2015Q4	us-gaap	Goodwill Goodwill	3700000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	11800000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	66000000	USD
	us-gaap	Gross Profit GrossProfit	112500000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	85500000	USD
	us-gaap	Gross Profit GrossProfit	160600000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16600000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39300000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.05
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.21
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.24
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.48
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3700000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9300000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3100000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-800000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	100000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-200000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-200000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1700000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6400000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7200000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	900000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	900000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2700000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-300000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2200000	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1800000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	100000	USD
	us-gaap	Interest Expense InterestExpense	300000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	100000	USD
	us-gaap	Interest Expense InterestExpense	200000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16600000	USD
CY2016Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	21100000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	35200000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	42900000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16000000	USD
CY2016Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	18400000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2600000	USD
CY2016Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3400000	USD
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	70800000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	86400000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	292000000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	332800000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	66900000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	73900000	USD
CY2012Q4	us-gaap	Line Of Credit LineOfCredit	15000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9200000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2500000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33100000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20800000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19800000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19900000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-3700000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-16600000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-20200000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39400000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	69600000	USD
	us-gaap	Operating Expenses OperatingExpenses	128800000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	105600000	USD
	us-gaap	Operating Expenses OperatingExpenses	199900000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16300000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-20100000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-39300000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	78600000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3200000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	10800000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	10500000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	9400000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7200000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	37500000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1400000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2800000	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2300000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4200000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13100000	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18500000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	100000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1200000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2016Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2015Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-200000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-400000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-400000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3900000	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12500000	USD
CY2015Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	100000	USD
CY2016Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2200000	USD
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	500000	USD
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	-400000	USD
CY2015Q3	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-1800000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	27500000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	20900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14300000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22000000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6800000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8700000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10400000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4800000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	9200000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	21700000	USD
CY2015Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1700000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3100000	USD
CY2016Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5100000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	8900000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54700000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77000000	USD
CY2016Q2	us-gaap	Recorded Unconditional Purchase Obligation Due Within One Year RecordedUnconditionalPurchaseObligationDueWithinOneYear	55500000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1200000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2300000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24400000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44200000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	68500000	USD
CY2015Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	2300000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-555400000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-594800000	USD
CY2015Q2	us-gaap	Revenues Revenues	93200000	USD
	us-gaap	Revenues Revenues	166000000	USD
CY2016Q2	us-gaap	Revenues Revenues	137300000	USD
	us-gaap	Revenues Revenues	253500000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	92900000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	165700000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	137300000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	253500000	USD
CY2016Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	0	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	45200000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	84600000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	69300000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	131400000	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	20700000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	36600000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	27600000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	52700000	USD
CY2014Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1300000	USD
CY2015Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1100000	USD
CY2015Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1200000	USD
CY2015Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3300000	USD
CY2016Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	5700000	USD
CY2016Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7900000	USD
CY2015Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1800000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	3000000	USD
CY2016Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	7300000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	13500000	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Stock Issued1 StockIssued1	7200000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	221200000	USD
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	246400000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	79600000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78700000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	83600000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	82800000	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Organization and Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of</font><font style="font-family:inherit;font-size:10pt;"> continuous glucose monitoring (“CGM”)</font><font style="font-family:inherit;font-size:10pt;"> systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with </font><font style="font-family:inherit;font-size:10pt;">U.S. GAAP</font><font style="font-family:inherit;font-size:10pt;"> requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates include excess or obsolete inventories, valuation of inventory, warranty accruals, employee bonus, clinical trial expenses, allowance for bad debt, refunds and rebates, including pharmacy rebates and share-based compensation expense. </font></div></div>

Files In Submission

Name	View Source	Status
0001093557-16-000624-index-headers.html	Edgar Link	pending
0001093557-16-000624-index.html	Edgar Link	pending
0001093557-16-000624.txt	Edgar Link	pending
0001093557-16-000624-xbrl.zip	Edgar Link	pending
dxcm-063016x10q.htm	Edgar Link	pending
dxcm-20160630.xml	Edgar Link	completed
dxcm-20160630.xsd	Edgar Link	pending
dxcm-20160630_cal.xml	Edgar Link	unprocessable
dxcm-20160630_def.xml	Edgar Link	unprocessable
dxcm-20160630_lab.xml	Edgar Link	unprocessable
dxcm-20160630_pre.xml	Edgar Link	unprocessable
dxcm063016ex1040.htm	Edgar Link	pending
dxcm063016exhibit1038.htm	Edgar Link	pending
dxcm063016exhibit1039.htm	Edgar Link	pending
dxcm063016exhibit1041.htm	Edgar Link	pending
dxcm06302016exhibit3101.htm	Edgar Link	pending
dxcm06302016exhibit3102.htm	Edgar Link	pending
dxcm06302016exhibit3201.htm	Edgar Link	pending
dxcm06302016exhibit3202.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g164526dsp7.jpg	Edgar Link	pending
pralbllcleasedraftfin_image1.jpg	Edgar Link	pending
pralbllcleasedraftfin_image2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DXCM
DEXCOM INC Stock $dxcm

2016 Q3 Form 10-Q Financial Statement

#000109355716000624 Filed on August 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM DEXCOM INC Stock $dxcm

2016 Q3 Form 10-Q Financial Statement

#000109355716000624 Filed on August 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM
DEXCOM INC Stock $dxcm